Catherine Lindgren
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 29
- CAR-T cell therapy research 25
- Cancer Immunotherapy and Biomarkers 4
- Immunology 18
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 9
- Biosimilars and Bioanalytical Methods 3
- Co-authors
- Michael C. Jensen (22 shared papers)Stanley R. Riddell (7 shared papers)Oliver W. Press (8 shared papers)Philip D. Greenberg (7 shared papers)Andrew Raubitschek (6 shared papers)Jinjuan Wang (6 shared papers)Xiaojun Qian (6 shared papers)Stephen J. Forman (5 shared papers)
- Journals
- Blood (13 papers)Journal of Clinical Oncology (7 papers)Journal of Immunotherapy (2 papers)Molecular Therapy (2 papers)Bone Marrow Transplantation (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Catherine Lindgren
39 papers receiving 2.9k citations
Catherine Lindgren's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 2.4k
- Immunology 971
- Genetics 708
- Hematology 234
- Biomedical Engineering 580
Countries citing papers authored by Catherine Lindgren
This map shows the geographic impact of Catherine Lindgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Lindgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Lindgren more than expected).
Fields of papers citing papers by Catherine Lindgren
This network shows the impact of papers produced by Catherine Lindgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Lindgren. The network helps show where Catherine Lindgren may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Lindgren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults Hit paper breakdown → | 2017 | 812 |
| 2 | Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells Hit paper breakdown → | 2008 | 575 |
| 3 | CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results Hit paper breakdown → | 2012 | 435 |
| 4 | 2007 | 176 | |
| 5 | 1988 | 108 | |
| 6 | 1982 | 88 | |
| 7 | Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial. | 1987 | 75 |
| 8 | 2018 | 72 | |
| 9 | 2004 | 72 | |
| 10 | Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells. | 1989 | 63 |
| 11 | 1992 | 54 | |
| 12 | Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial. | 1995 | 53 |
| 13 | 2018 | 51 | |
| 14 | 1996 | 35 | |
| 15 | 2016 | 33 | |
| 16 | 1997 | 33 | |
| 17 | Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro. | 1989 | 26 |
| 18 | Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma. | 1997 | 24 |
| 19 | 2022 | 17 | |
| 20 | 2021 | 16 |
About Catherine Lindgren
Catherine Lindgren is a scholar working on Oncology, Immunology, Hematology, Pathology and Forensic Medicine and Genetics, having authored 40 papers that have together received 3.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (25 papers), Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (9 papers), Lymphoma Diagnosis and Treatment (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Biosimilars and Bioanalytical Methods (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (971 citations), Genetics (708 citations), Hematology (234 citations) and Biomedical Engineering (580 citations). Catherine Lindgren has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Michael C. Jensen, Stanley R. Riddell, Oliver W. Press, Philip D. Greenberg, Andrew Raubitschek, Jinjuan Wang, Xiaojun Qian, Stephen J. Forman, Brian G. Till and Stephanie Mgebroff. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Immunotherapy, Molecular Therapy and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.